Paroxysmal Nocturnal Hemoglobinuria
Sunday October 30, 2005
In this disorder, a biochemical defect causes abnormal red blood cell breakdown, blood clots in veins, and a deficiency in the production of all types of blood cells. Research, including ... Read More
Gene may play role in rare muscular disease
Friday October 28, 2005
University of Texas Southwestern Medical Center researchers have discovered a mouse gene that may play a role in centronuclear myopathy, a group of rare inherited muscle diseases in humans. Mice ... Read More
Drug may be effective for inflammatory eye diseases
Wednesday October 26, 2005
The immunosuppressive drug mycophenolate mofetil may be effective in controlling inflammatory eye diseases. Researchers at Johns Hopkins' Wilmer Eye Institute gave the drug to 84 individuals, of whom 61% had ... Read More
Gastroschisis
Sunday October 23, 2005
Gastroschisis is a birth defect in which an infant is born with some of or all his/her intestines on the outside of the abdomen due to an abnormal opening in ... Read More
Children with very severe aplastic anemia show better response to immunosuppression
Thursday October 20, 2005
Aplastic anemia is a life-threatening disease in which the bone marrow fails to make enough of all types of blood cells. The immune system is thought to play a role ... Read More
Lenalidomide plus dexamethasone can be initial treatment for myeloma
Wednesday October 19, 2005
Lenalidomide (Revlimid) and dexamethasone have been used together to treat recurrent or highly resistant forms of myeloma, a bone marrow cancer. Researchers at the Mayo Clinic studied whether the combination ... Read More
Takayasu Arteritis
Sunday October 16, 2005
Takayasu arteritis is a chronic inflammatory disease of the large arteries. Although its exact cause is as yet unknown, studies suggest it may arise after certain types of infections or ... Read More
Orphan drug troxacitabine (Troxatyl) approved for AML in EU
Thursday October 13, 2005
On September 27, 2005, the European Commission approved orphan drug status for troxacitabine (Troxatyl injection, made by SGX Pharmaceuticals) for the treatment of acute myeloid leukemia (AML), a blood cancer. ... Read More
Genzyme loses UK ruling on Cerezyme discount
Tuesday October 11, 2005
In 2003, the Office of Fair Trading in the United Kingdom issued a decision against Genzyme Limited, finding that Genzyme had priced its drug Cerezyme, used to treat Gaucher disease, ... Read More
Progressive Supranuclear Palsy
Sunday October 9, 2005
Progressive supranuclear palsy is a degenerative brain disorder that gets worse over time. Its symptoms may be misdiagnosed as Alzheimer's disease, alcohol abuse, or stroke.
Gene replacement therapy in Leber congenital amaurosis
Friday October 7, 2005
To date, researchers have identified eight genes that cause different types of Leber congenital amaurosis, a retinal disease that causes loss of vision. Researchers from Harvard Medical School have been ... Read More
Two Fanconi anemia research studies
Tuesday October 4, 2005
A team of researchers, led by scientists at Rockefeller University, have found a gene mutation not previously known to be related to Fanconi anemia, called BRIP1. Its protein, BACH1, helps ... Read More
Juvenile Retinoschisis
Sunday October 2, 2005
This X-linked genetic disorder causes impaired vision, with symptoms similar to macular degeneration, primarily in boys. Retinal detachments and vitreous hemorrhage may also occur.
